3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pain, Postoperative
5
Breast Neoplasms
3
Thyroid Neoplasms
2
Chronic Pain
2
Brain Neoplasms
2
Agnosia
2
Urinary Bladder Neoplasms
1
Thrombosis
1
Sleep Initiation and Maintenance Disorders
1
Sigmoid Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Pain
1
Opioid Consumption, Postoperative
1
Neuroinflammatory Diseases
1
Meningioma
1
Lung Injury
1
Inflammation
1
Hypoxia
1
Hyperthyroidism
1
Goiter
1
Elderly
1
Delirium
1
Colorectal Neoplasms
1
Breast Cancer Female
1
Abdominal Cancer Surgeries
1
Interventions
phenazine
1
Surveys and Questionnaires
1
Sufentanil
1
Promethazine
1
Ondansetron
1
Famotidine
1
Electroacupuncture
1
Electric Stimulation
1
Diphenhydramine
1
Dexamethasone
1
Calcium Dobesilate
1
Anesthesia, General
1
((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Postoperative Nausea and Vomiting
×
Dexmedetomidine
×
1 year
×
Clear all
No trials found.